Jounce Therapeutics
Why Robinhood?
You can watch JNCE and buy or sell other stocks, ETFs, and their options commission-free!About JNCE
Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors.
JNCE Key Statistics
Stock Snapshot
The current Jounce Therapeutics(JNCE) stock price is $1.88, with a market capitalization of 98.95M. The stock trades at a price-to-earnings (P/E) ratio of -1.91.
During the trading day, Jounce Therapeutics(JNCE) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 2.01M.
Over the past 52 weeks, Jounce Therapeutics(JNCE) stock has traded between a high of $5.87 and a low of $0.58.
Over the past 52 weeks, Jounce Therapeutics(JNCE) stock has traded between a high of $5.87 and a low of $0.58.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.